Rapid CTA 360
Overview
Rapid CTA 360, developed by RapidAI (formerly iSchemaView), is an advanced AI-powered imaging solution designed to revolutionize stroke diagnosis and treatment planning. It provides fully automated, high-quality 3D reconstructions of head, neck, and aortic arch CT angiography (CTA) scans within minutes. The tool enhances visibility of distal occlusions and collateral flow through color-coded overlays that identify brain regions with reduced blood vessel density. Physicians can view and analyze these 3D reconstructions from multiple angles, facilitating precise stroke diagnosis and treatment decisions. Rapid CTA 360 is part of the broader RapidAI platform, which offers a comprehensive suite of AI tools for acute stroke care, aiming to expedite time to treatment, improve workflow efficiencies, and ultimately enhance patient outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated 3D CTA reconstructions of head, neck, and aortic arch
- Color-coded overlays for identifying brain regions with reduced blood vessel density
- Multi-angle 3D reconstructions for precise visualization of vasculature
- Automated assessment of collateral vessels
- Mobile device access for remote viewing and analysis
- Integration with PACS and reporting systems
- AI-driven worklist prioritization (as part of RapidAI platform)
- Reduced manual steps and cognitive burden for radiologists
- Facilitates clinical decision-making and patient triage
- Supports collaboration between community hospitals and specialists
Use Cases
- Acute ischemic stroke diagnosis and treatment planning
- Identification of large vessel occlusions (LVO)
- Patient selection for mechanical thrombectomy
- Expediting time between CT and CTA scans
- Remote image review and consultation
- Workflow triage and prioritization of medical images
What Physicians Need to Know
Rapid CTA is a powerful AI-driven tool for rapid assessment of cerebrovascular disease, particularly in acute stroke. Utilize its automated analysis for quick identification of large vessel occlusions, assessment of collateral flow, and 3D vascular reconstructions to expedite diagnosis and treatment decisions. Always integrate the AI findings with your comprehensive clinical evaluation and source image interpretation, as the software is a decision support tool, not a replacement for expert review. Leverage its mobile accessibility for timely decision-making and inter-hospital transfer coordination.
RapidAI's platform, including Rapid CTA, is designed for seamless integration into existing clinical workflows and IT infrastructure. It utilizes RESTful APIs and supports JSON data format for data exchange, with OAuth 2.0 for secure authentication. This allows for integration with PACS, EMR systems, and mobile devices, ensuring results are delivered quickly and efficiently to relevant care team members.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact vendor for pricing — N/A |
| Deployment | On-premise, cloud, or hybrid infrastructure (Rapid Edge Cloud) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated Rapid CTA 360 (K251151) is FDA-cleared as Radiological Computer-Assisted Triage And Notification Software. It provides 3D imaging solutions for Computed Tomography Angiography, offering clear maps with colored overlays to identify brain regions with reduced blood vessel density and 3D reconstructions of vasculature for stroke diagnosis and treatment planning. |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Neurology, Radiology |
What the Web Says
Rapid CTA 360, part of the RapidAI platform, is an AI-powered software designed to assist physicians in the rapid detection and assessment of stroke by analyzing CT angiography images. It aims to improve the efficiency of the diagnostic process and facilitate quicker treatment decisions for stroke patients. The software provides automated interpretation of CTA maps, including color-coded overlays to identify occlusions and 3D reconstructions for enhanced visualization. While it has shown potential in reducing time-to-intervention and improving diagnostic accuracy when used in conjunction with clinician interpretation, some studies highlight limitations in its standalone accuracy and the need for more robust evidence on patient outcomes and cost-effectiveness.
Overall: MixedStrengths
- Potential to improve acute stroke care by creating efficiencies in the diagnostic process.
- Provides fast, fully-automated, and easy-to-interpret imaging.
- Offers remote viewing capabilities for physicians on various devices.
- Helps identify the area of occlusion and quantify impacted vasculature with color-coded overlays and 3D reconstructions.
- Can reduce CTA-to-groin puncture time, potentially improving patient outcomes.
- Facilitates communication and collaboration among stroke teams.
Limitations
- Impact on many important patient outcomes (e.g., harms, mortality, quality of life) is uncertain due to limited evidence.
- Cost-effectiveness for stroke detection is currently unknown.
- Low-certainty evidence for its effects on functional status and response to therapy.
- Standalone diagnostic accuracy can be limited, with instances of false positives.
- Ethical considerations regarding patient autonomy, privacy, transparency, access, and algorithmic bias.
- Some users have reported glitches with the mobile app, including issues with notifications and logging in.
Based on reviews from: NCBI Bookshelf, Indeed.com, Canadian Journal of Health Technologies, NeuroNews International, Apple App Store, Reddit, Xtalks, RapidAI, G2, Capterra
Last updated: 2026-07-21
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Rapid CTA 360
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Rapid CTA 360.
